SYK
Stryker Corporation
Price Chart
Latest Quote
$307.80
+6.66 (+2.21%)
Current Price
| Previous Close | $301.14 |
| Open | $301.19 |
| Day High | $311.54 |
| Day Low | $299.36 |
| Volume | 2,226,686 |
Stock Information
| Quarterly Dividend / Yield | $3.52 / 1.13% |
| Shares Outstanding | 383.36M |
| Quarterly Dividend Yield | 1.13% |
| Quarterly Dividend | $3.52 |
| Total Debt | $15.23B |
| Cash Equivalents | $2.96B |
| Revenue | $25.27B |
| Net Income | $3.34B |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $118.00B |
| P/E Ratio | 35.67 |
| EPS (TTM) | $8.63 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $131.33B |
| Sales | $25.27B |
| Income | $3.34B |
| Book/sh | $58.61 |
| Cash/sh | $7.73 |
| Employees | 56K |
Financial Ratios
| Quick Ratio | 1.03 |
| Current Ratio | 2.11 |
| Debt/Eq | 66.30 |
| EPS Growth TTM | 13.90% |
Returns & Margins
| ROA | 7.72% |
| ROE | 15.20% |
| Gross Margin | 64.70% |
| Operating Margin | 17.82% |
| Profit Margin | 13.21% |
Ownership
| Insider Ownership | 5.37% |
| Institutional Ownership | 82.37% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 18.40 |
| PEG | 1.48 |
| P/S | 4.67 |
| P/B | 5.25 |
Analyst Data
| Recommendation | buy |
| Target Price | $386.80 |
Technical Indicators
| SMA20 | $306.30 |
| SMA50 | $313.00 |
| SMA200 | $349.51 |
| RSI | 51.72 |
| ATR | 8.5914 |
| Shares Float | 347.57M |
| Short Float | 1.70% |
| Short Ratio | 1.94 |
| Volatility | 0.79 |
| Rel Volume | 0.84 |
Performance History
| Week | +0.71% |
| Month | -3.13% |
| Quarter | -9.16% |
| 6 Months | -12.02% |
| YTD | -11.36% |
| Year | -16.77% |
| 3 Years | +12.47% |
| 5 Years | +26.72% |
| 10 Years | +196.31% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $307.80 | 2,226,686 |
| 2026-06-17 | $301.14 | 2,930,400 |
| 2026-06-16 | $310.58 | 1,754,700 |
| 2026-06-15 | $307.94 | 2,444,400 |
| 2026-06-12 | $312.20 | 3,182,300 |
| 2026-06-11 | $305.64 | 2,030,200 |
| 2026-06-10 | $308.84 | 1,678,400 |
| 2026-06-09 | $314.01 | 2,701,700 |
| 2026-06-08 | $301.53 | 1,676,900 |
| 2026-06-05 | $305.66 | 2,123,100 |
| 2026-06-04 | $301.21 | 2,476,600 |
| 2026-06-03 | $295.00 | 2,188,700 |
| 2026-06-02 | $293.30 | 2,995,600 |
| 2026-06-01 | $299.46 | 2,950,200 |
| 2026-05-29 | $305.09 | 6,064,600 |
| 2026-05-28 | $307.63 | 2,439,000 |
| 2026-05-27 | $305.94 | 3,672,800 |
| 2026-05-26 | $313.00 | 2,834,600 |
| 2026-05-22 | $316.48 | 1,893,100 |
| 2026-05-21 | $313.50 | 2,890,700 |
| 2026-05-20 | $321.49 | 3,020,300 |
| 2026-05-19 | $317.75 | 3,575,800 |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
đ° Latest News
3 Big Reasons SYK Should Be On Your Watchlist
StockStory âĸ 2026-06-16T13:05:04Z
Stryker (SYK) Stock After 16.5% One-Year Slide Is The Market Overreacting
Simply Wall St. âĸ 2026-06-13T09:11:41Z
Stryker Weighs Cyber Setback Against Robotics Strength And Global Growth
Simply Wall St. âĸ 2026-06-13T06:09:56Z
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Zacks âĸ 2026-06-12T17:16:00Z
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
Zacks âĸ 2026-06-12T15:30:05Z
Medtronic Bets on Ablation, Robotics, and Hypertension
Zacks âĸ 2026-06-11T12:47:00Z
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
Zacks âĸ 2026-06-10T13:21:00Z
Is Medtronic Stock a Buy at 14x Forward Earnings?
Zacks âĸ 2026-06-10T13:18:00Z
Strykerâs Pangea Europe Launch And What It Means For NYSE SYK Investors
Simply Wall St. âĸ 2026-06-10T02:11:18Z
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
Zacks âĸ 2026-06-09T14:07:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $8,590,000,000 | $7,728,000,000 | $7,047,000,000 | $6,500,000,000 |
| Cost Of Revenue | $9,051,000,000 | $8,155,000,000 | $7,440,000,000 | $6,871,000,000 |
| Total Revenue | $25,116,000,000 | $22,595,000,000 | $20,498,000,000 | $18,449,000,000 |
| Operating Revenue | $25,116,000,000 | $22,595,000,000 | $20,498,000,000 | $18,449,000,000 |
| Expenses | ||||
| Interest Expense | $607,000,000 | $409,000,000 | $363,000,000 | - |
| Total Expenses | $20,057,000,000 | $17,929,000,000 | $16,574,000,000 | $15,338,000,000 |
| Other Income Expense | $62,000,000 | $-765,000,000 | $112,000,000 | $-428,000,000 |
| Other Non Operating Income Expenses | $232,000,000 | $212,000,000 | $148,000,000 | $-158,000,000 |
| Net Non Operating Interest Income Expense | $-607,000,000 | $-409,000,000 | $-363,000,000 | - |
| Interest Expense Non Operating | $607,000,000 | $409,000,000 | $363,000,000 | - |
| Operating Expense | $11,006,000,000 | $9,774,000,000 | $9,134,000,000 | $8,467,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Net Interest Income | $-607,000,000 | $-409,000,000 | $-363,000,000 | - |
| Normalized Income | $3,368,246,345 | $3,830,388,603 | $3,196,032,000 | $2,595,330,000 |
| Net Income From Continuing And Discontinued Operation | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Total Operating Income As Reported | $4,889,000,000 | $3,689,000,000 | $3,888,000,000 | $2,841,000,000 |
| Net Income Common Stockholders | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Net Income | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Net Income Including Noncontrolling Interests | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Net Income Continuous Operations | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Pretax Income | $4,514,000,000 | $3,492,000,000 | $3,673,000,000 | $2,683,000,000 |
| Special Income Charges | $-170,000,000 | $-977,000,000 | $-36,000,000 | $-270,000,000 |
| Operating Income | $5,059,000,000 | $4,666,000,000 | $3,924,000,000 | $3,111,000,000 |
| Depreciation Amortization Depletion Income Statement | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Depreciation And Amortization In Income Statement | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Amortization Of Intangibles Income Statement | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Gross Profit | $16,065,000,000 | $14,440,000,000 | $13,058,000,000 | $11,578,000,000 |
| Per Share | ||||
| Diluted EPS | $8.40 | $7.76 | $8.25 | $6.17 |
| Basic EPS | $8.49 | $7.86 | $8.34 | $6.23 |
| Other | ||||
| Tax Effect Of Unusual Items | $-47,753,655 | $-139,611,397 | $-4,968,000 | $-32,670,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $6,484,000,000 | $5,928,000,000 | $5,100,000,000 | $4,379,000,000 |
| Total Unusual Items | $-170,000,000 | $-977,000,000 | $-36,000,000 | $-270,000,000 |
| Total Unusual Items Excluding Goodwill | $-170,000,000 | $-977,000,000 | $-36,000,000 | $-270,000,000 |
| Reconciled Depreciation | $1,193,000,000 | $1,050,000,000 | $1,028,000,000 | $998,000,000 |
| EBITDA (Bullshit earnings) | $6,314,000,000 | $4,951,000,000 | $5,064,000,000 | $4,109,000,000 |
| EBIT | $5,121,000,000 | $3,901,000,000 | $4,036,000,000 | $3,111,000,000 |
| Diluted Average Shares | $386,500,000 | $385,600,000 | $383,700,000 | $382,200,000 |
| Basic Average Shares | $382,200,000 | $381,000,000 | $379,600,000 | $378,200,000 |
| Diluted NI Availto Com Stockholders | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Tax Provision | $1,268,000,000 | $499,000,000 | $508,000,000 | $325,000,000 |
| Impairment Of Capital Assets | $170,000,000 | $977,000,000 | $36,000,000 | $270,000,000 |
| Amortization | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Research And Development | $1,623,000,000 | $1,466,000,000 | $1,388,000,000 | $1,454,000,000 |
| Selling General And Administration | $8,651,000,000 | $7,685,000,000 | $7,111,000,000 | $6,386,000,000 |
| Other Special Charges | - | - | $18,000,000 | $-15,000,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,552,000,000 | $384,000,000 | $-1,243,000,000 | $-3,149,000,000 |
| Total Assets | $47,844,000,000 | $42,971,000,000 | $39,912,000,000 | $36,884,000,000 |
| Total Non Current Assets | $33,089,000,000 | $28,124,000,000 | $27,394,000,000 | $26,609,000,000 |
| Other Non Current Assets | $3,143,000,000 | $2,684,000,000 | $2,673,000,000 | $2,464,000,000 |
| Non Current Deferred Assets | $1,098,000,000 | $1,742,000,000 | $1,670,000,000 | $1,410,000,000 |
| Non Current Deferred Taxes Assets | $1,098,000,000 | $1,742,000,000 | $1,670,000,000 | $1,410,000,000 |
| Goodwill And Other Intangible Assets | $24,972,000,000 | $20,250,000,000 | $19,836,000,000 | $19,765,000,000 |
| Other Intangible Assets | $5,681,000,000 | $4,395,000,000 | $4,593,000,000 | $4,885,000,000 |
| Current Assets | $14,755,000,000 | $14,847,000,000 | $12,518,000,000 | $10,275,000,000 |
| Other Current Assets | $1,306,000,000 | $1,593,000,000 | $857,000,000 | $787,000,000 |
| Inventory | $5,310,000,000 | $4,774,000,000 | $4,843,000,000 | $3,995,000,000 |
| Receivables | $4,039,000,000 | $3,987,000,000 | $3,765,000,000 | $3,565,000,000 |
| Accounts Receivable | $4,039,000,000 | $3,987,000,000 | $3,765,000,000 | $3,565,000,000 |
| Allowance For Doubtful Accounts Receivable | $-216,000,000 | $-213,000,000 | $-182,000,000 | $-154,000,000 |
| Gross Accounts Receivable | $4,255,000,000 | $4,200,000,000 | $3,947,000,000 | $3,719,000,000 |
| Cash Cash Equivalents And Short Term Investments | $4,100,000,000 | $4,493,000,000 | $3,053,000,000 | $1,928,000,000 |
| Cash And Cash Equivalents | $4,011,000,000 | $3,652,000,000 | $2,971,000,000 | $1,844,000,000 |
| Prepaid Assets | - | - | - | $787,000,000 |
| Debt | ||||
| Net Debt | $11,848,000,000 | $9,945,000,000 | $10,024,000,000 | $11,204,000,000 |
| Total Debt | $15,859,000,000 | $13,597,000,000 | $12,995,000,000 | $13,048,000,000 |
| Long Term Debt And Capital Lease Obligation | $14,859,000,000 | $12,188,000,000 | $10,901,000,000 | $11,857,000,000 |
| Long Term Debt | $14,859,000,000 | $12,188,000,000 | $10,901,000,000 | $11,857,000,000 |
| Current Debt And Capital Lease Obligation | $1,000,000,000 | $1,409,000,000 | $2,094,000,000 | $1,191,000,000 |
| Current Debt | $1,000,000,000 | $1,409,000,000 | $2,094,000,000 | $1,191,000,000 |
| Other Current Borrowings | $1,000,000,000 | $1,409,000,000 | $2,094,000,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $25,424,000,000 | $22,337,000,000 | $21,319,000,000 | $20,268,000,000 |
| Total Non Current Liabilities Net Minority Interest | $17,630,000,000 | $14,721,000,000 | $13,398,000,000 | $13,965,000,000 |
| Other Non Current Liabilities | $2,369,000,000 | $2,184,000,000 | $1,930,000,000 | $1,467,000,000 |
| Tradeand Other Payables Non Current | $402,000,000 | $349,000,000 | $567,000,000 | $641,000,000 |
| Current Liabilities | $7,794,000,000 | $7,616,000,000 | $7,921,000,000 | $6,303,000,000 |
| Payables And Accrued Expenses | $5,199,000,000 | $4,804,000,000 | $4,349,000,000 | $3,963,000,000 |
| Payables | $2,554,000,000 | $2,538,000,000 | $2,212,000,000 | $1,989,000,000 |
| Dividends Payable | $337,000,000 | $320,000,000 | $304,000,000 | $284,000,000 |
| Total Tax Payable | $418,000,000 | $539,000,000 | $391,000,000 | $292,000,000 |
| Income Tax Payable | $418,000,000 | $539,000,000 | $391,000,000 | $292,000,000 |
| Accounts Payable | $1,799,000,000 | $1,679,000,000 | $1,517,000,000 | $1,413,000,000 |
| Equity | ||||
| Common Stock Equity | $22,420,000,000 | $20,634,000,000 | $18,593,000,000 | $16,616,000,000 |
| Total Equity Gross Minority Interest | $22,420,000,000 | $20,634,000,000 | $18,593,000,000 | $16,616,000,000 |
| Stockholders Equity | $22,420,000,000 | $20,634,000,000 | $18,593,000,000 | $16,616,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-687,000,000 | $-293,000,000 | $-416,000,000 | $-221,000,000 |
| Other Equity Adjustments | $-687,000,000 | $-293,000,000 | $-416,000,000 | $-221,000,000 |
| Retained Earnings | $20,472,000,000 | $18,528,000,000 | $16,771,000,000 | $14,765,000,000 |
| Other | ||||
| Ordinary Shares Number | $382,500,000 | $381,400,000 | $380,100,000 | $378,700,000 |
| Share Issued | $382,500,000 | $381,400,000 | $380,100,000 | $378,700,000 |
| Tangible Book Value | $-2,552,000,000 | $384,000,000 | $-1,243,000,000 | $-3,149,000,000 |
| Invested Capital | $38,279,000,000 | $34,231,000,000 | $31,588,000,000 | $29,664,000,000 |
| Working Capital | $6,961,000,000 | $7,231,000,000 | $4,597,000,000 | $3,972,000,000 |
| Total Capitalization | $37,279,000,000 | $32,822,000,000 | $29,494,000,000 | $28,473,000,000 |
| Additional Paid In Capital | $2,597,000,000 | $2,361,000,000 | $2,200,000,000 | $2,034,000,000 |
| Capital Stock | $38,000,000 | $38,000,000 | $38,000,000 | $38,000,000 |
| Common Stock | $38,000,000 | $38,000,000 | $38,000,000 | $38,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,595,000,000 | $1,403,000,000 | $1,478,000,000 | $1,149,000,000 |
| Current Accrued Expenses | $2,645,000,000 | $2,266,000,000 | $2,137,000,000 | $1,974,000,000 |
| Goodwill | $19,291,000,000 | $15,855,000,000 | $15,243,000,000 | $14,880,000,000 |
| Net PPE | $3,876,000,000 | $3,448,000,000 | $3,215,000,000 | $2,970,000,000 |
| Accumulated Depreciation | $-3,661,000,000 | $-3,235,000,000 | $-3,129,000,000 | $-2,835,000,000 |
| Gross PPE | $7,537,000,000 | $6,683,000,000 | $6,344,000,000 | $5,805,000,000 |
| Machinery Furniture Equipment | $5,744,000,000 | $5,056,000,000 | $4,652,000,000 | $4,066,000,000 |
| Properties | $1,793,000,000 | $1,627,000,000 | $1,692,000,000 | $1,739,000,000 |
| Finished Goods | $3,546,000,000 | $3,291,000,000 | $3,271,000,000 | $2,641,000,000 |
| Work In Process | $415,000,000 | $336,000,000 | $330,000,000 | $348,000,000 |
| Raw Materials | $1,349,000,000 | $1,147,000,000 | $1,242,000,000 | $1,006,000,000 |
| Other Short Term Investments | $89,000,000 | $841,000,000 | $82,000,000 | $84,000,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $4,283,000,000 | $3,487,000,000 | $3,136,000,000 | $2,036,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $5,044,000,000 | $4,242,000,000 | $3,711,000,000 | $2,624,000,000 |
| Cash Flow From Continuing Operating Activities | $5,044,000,000 | $4,242,000,000 | $3,711,000,000 | $2,624,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-761,000,000 | $-755,000,000 | $-575,000,000 | $-588,000,000 |
| Investing Cash Flow | $-4,866,000,000 | $-3,000,000,000 | $-962,000,000 | $-2,924,000,000 |
| Cash Flow From Continuing Investing Activities | $-4,866,000,000 | $-3,000,000,000 | $-962,000,000 | $-2,924,000,000 |
| Net Other Investing Changes | $-60,000,000 | $133,000,000 | $3,000,000 | $39,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $113,000,000 | $-525,000,000 | $-1,594,000,000 | $-749,000,000 |
| Cash Flow From Continuing Financing Activities | $113,000,000 | $-525,000,000 | $-1,594,000,000 | $-749,000,000 |
| Net Other Financing Charges | $-182,000,000 | $-246,000,000 | $-178,000,000 | $-170,000,000 |
| Cash Dividends Paid | $-1,284,000,000 | $-1,219,000,000 | $-1,139,000,000 | $-1,051,000,000 |
| Common Stock Dividend Paid | $-1,284,000,000 | $-1,219,000,000 | $-1,139,000,000 | $-1,051,000,000 |
| Repurchase Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-1,400,000,000 | $-2,039,000,000 | $-2,058,000,000 | $-653,000,000 |
| Issuance Of Debt | $2,979,000,000 | $3,011,000,000 | $1,241,000,000 | $1,500,000,000 |
| Interest Paid Supplemental Data | $582,000,000 | $396,000,000 | $356,000,000 | $324,000,000 |
| Income Tax Paid Supplemental Data | $1,002,000,000 | $989,000,000 | $693,000,000 | $505,000,000 |
| End Cash Position | $4,011,000,000 | $3,652,000,000 | $2,971,000,000 | $1,844,000,000 |
| Beginning Cash Position | $3,652,000,000 | $2,971,000,000 | $1,844,000,000 | $2,944,000,000 |
| Effect Of Exchange Rate Changes | $68,000,000 | $-36,000,000 | $-28,000,000 | $-51,000,000 |
| Changes In Cash | $291,000,000 | $717,000,000 | $1,155,000,000 | $-1,049,000,000 |
| Net Issuance Payments Of Debt | $1,579,000,000 | $940,000,000 | $-277,000,000 | $472,000,000 |
| Net Short Term Debt Issuance | $0 | $-32,000,000 | $540,000,000 | $-375,000,000 |
| Net Long Term Debt Issuance | $1,579,000,000 | $972,000,000 | $-817,000,000 | $847,000,000 |
| Long Term Debt Payments | $-1,400,000,000 | $-2,039,000,000 | $-2,058,000,000 | $-653,000,000 |
| Long Term Debt Issuance | $2,979,000,000 | $3,011,000,000 | $1,241,000,000 | $1,500,000,000 |
| Net Investment Purchase And Sale | $750,000,000 | $-750,000,000 | $0 | $188,000,000 |
| Net Business Purchase And Sale | $-4,795,000,000 | $-1,628,000,000 | $-390,000,000 | $-2,563,000,000 |
| Sale Of Business | $165,000,000 | $0 | $0 | - |
| Purchase Of Business | $-4,960,000,000 | $-1,628,000,000 | $-390,000,000 | $-2,563,000,000 |
| Net PPE Purchase And Sale | $-761,000,000 | $-755,000,000 | $-575,000,000 | $-588,000,000 |
| Purchase Of PPE | $-761,000,000 | $-755,000,000 | $-575,000,000 | $-588,000,000 |
| Change In Working Capital | $-373,000,000 | $-683,000,000 | $-517,000,000 | $-1,240,000,000 |
| Change In Other Working Capital | $-470,000,000 | $-306,000,000 | $-134,000,000 | $-107,000,000 |
| Change In Payables And Accrued Expense | $267,000,000 | $150,000,000 | $589,000,000 | $208,000,000 |
| Change In Accrued Expense | $318,000,000 | $74,000,000 | $516,000,000 | $156,000,000 |
| Change In Payable | $-51,000,000 | $76,000,000 | $73,000,000 | $52,000,000 |
| Change In Account Payable | $94,000,000 | $192,000,000 | $77,000,000 | $290,000,000 |
| Change In Tax Payable | $-145,000,000 | $-116,000,000 | $-4,000,000 | $-238,000,000 |
| Change In Income Tax Payable | $-145,000,000 | $-116,000,000 | $-4,000,000 | $-238,000,000 |
| Change In Inventory | $-297,000,000 | $-206,000,000 | $-797,000,000 | $-762,000,000 |
| Change In Receivables | $127,000,000 | $-321,000,000 | $-175,000,000 | $-579,000,000 |
| Changes In Account Receivables | $127,000,000 | $-321,000,000 | $-175,000,000 | $-579,000,000 |
| Other Non Cash Items | $173,000,000 | $46,000,000 | $-17,000,000 | $12,000,000 |
| Stock Based Compensation | $243,000,000 | $229,000,000 | $205,000,000 | $168,000,000 |
| Asset Impairment Charge | $170,000,000 | $977,000,000 | $36,000,000 | $270,000,000 |
| Deferred Tax | $392,000,000 | $-370,000,000 | $-206,000,000 | $58,000,000 |
| Deferred Income Tax | $392,000,000 | $-370,000,000 | $-206,000,000 | $58,000,000 |
| Depreciation Amortization Depletion | $1,193,000,000 | $1,050,000,000 | $1,028,000,000 | $998,000,000 |
| Depreciation And Amortization | $1,193,000,000 | $1,050,000,000 | $1,028,000,000 | $998,000,000 |
| Amortization Cash Flow | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Amortization Of Intangibles | $732,000,000 | $623,000,000 | $635,000,000 | $627,000,000 |
| Depreciation | $461,000,000 | $427,000,000 | $393,000,000 | $371,000,000 |
| Net Income From Continuing Operations | $3,246,000,000 | $2,993,000,000 | $3,165,000,000 | $2,358,000,000 |
| Sale Of Investment | - | $148,000,000 | $54,000,000 | $240,000,000 |
| Purchase Of Investment | - | $-808,000,000 | $-52,000,000 | $-52,000,000 |
| Common Stock Payments | - | - | - | - |
Fetched: 2026-06-14